speb/financial-data huggingface dataset:
TORC.V income_statement (annual, 2025-06-30) — Net Income Including Noncontrolling Interests: -775514.00
TORC.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -291961.00
TORC.V income_statement (annual, 2025-06-30) — Net Interest Income: -80878.00
TORC.V income_statement (quarterly, 2025-06-30) — Net Interest Income: -22711.00
TORC.V cash_flow (annual, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
TORC.V cash_flow (annual, 2025-06-30) — Net Long Term Debt Issuance: 0.00
TORC.V income_statement (annual, 2025-06-30) — Net Non Operating Interest Income Expense: -80878.00
TORC.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -22711.00
TORC.V cash_flow (annual, 2025-06-30) — Net Other Investing Changes: 53789.00
TORC.V cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 196519.00
TORC.V balance_sheet (annual, 2025-06-30) — Net PPE: 4366059.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Net PPE: 4366059.00
TORC.V cash_flow (annual, 2025-06-30) — Net PPE Purchase And Sale: -212602.00
TORC.V balance_sheet (annual, 2025-06-30) — Net Tangible Assets: 2959790.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 2959790.00
TORC.V balance_sheet (annual, 2025-06-30) — Non Current Prepaid Assets: 0.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 0.00
TORC.V income_statement (annual, 2025-06-30) — Normalized EBITDA: -537799.00
TORC.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -105019.00
TORC.V income_statement (annual, 2025-06-30) — Normalized Income: -619985.00
TORC.V income_statement (quarterly, 2025-06-30) — Normalized Income: -127818.00
TORC.V cash_flow (annual, 2025-06-30) — Operating Cash Flow: -279137.00
TORC.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 48690.00
TORC.V cash_flow (annual, 2025-06-30) — Operating Gains Losses: 556.00
TORC.V income_statement (annual, 2025-06-30) — Operating Income: -539107.00
TORC.V income_statement (quarterly, 2025-06-30) — Operating Income: -105107.00
TORC.V income_statement (annual, 2025-06-30) — Operating Revenue: 0.00
TORC.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
TORC.V balance_sheet (annual, 2025-06-30) — Ordinary Shares Number: 9274385.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 9274385.00
TORC.V balance_sheet (annual, 2025-06-30) — Other Current Borrowings: 680683.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 680683.00
TORC.V balance_sheet (annual, 2025-06-30) — Other Equity Adjustments: 1534016.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 1534016.00
TORC.V income_statement (annual, 2025-06-30) — Other Gand A: 119224.00
TORC.V income_statement (quarterly, 2025-06-30) — Other Gand A: 36072.00
TORC.V income_statement (annual, 2025-06-30) — Other Income Expense: -155529.00
TORC.V income_statement (quarterly, 2025-06-30) — Other Income Expense: -164143.00
TORC.V cash_flow (annual, 2025-06-30) — Other Non Cash Items: 138950.00
TORC.V cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 38544.00
TORC.V income_statement (annual, 2025-06-30) — Other Operating Expenses: 365597.00
TORC.V income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 57908.00
TORC.V balance_sheet (annual, 2025-06-30) — Payables And Accrued Expenses: 784168.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 784168.00
TORC.V balance_sheet (annual, 2025-06-30) — Prepaid Assets: 22364.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 22364.00
TORC.V income_statement (annual, 2025-06-30) — Pretax Income: -775514.00
TORC.V income_statement (quarterly, 2025-06-30) — Pretax Income: -291961.00
TORC.V cash_flow (annual, 2025-06-30) — Purchase Of PPE: -212602.00
TORC.V balance_sheet (annual, 2025-06-30) — Receivables: 6169.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Receivables: 6169.00
TORC.V income_statement (annual, 2025-06-30) — Reconciled Depreciation: 3176.00
TORC.V income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 451.00
TORC.V balance_sheet (annual, 2025-06-30) — Retained Earnings: -9722009.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -9722009.00
TORC.V income_statement (annual, 2025-06-30) — Salaries And Wages: 29606.00
TORC.V income_statement (quarterly, 2025-06-30) — Salaries And Wages: 5083.00
TORC.V income_statement (annual, 2025-06-30) — Selling And Marketing Expense: 994.00
TORC.V income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 0.00
TORC.V income_statement (annual, 2025-06-30) — Selling General And Administration: 170334.00
TORC.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 46748.00
TORC.V balance_sheet (annual, 2025-06-30) — Share Issued: 9274385.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 9274385.00
TORC.V income_statement (annual, 2025-06-30) — Special Income Charges: -164084.00
TORC.V income_statement (quarterly, 2025-06-30) — Special Income Charges: -164084.00
TORC.V cash_flow (annual, 2025-06-30) — Stock Based Compensation: 2023.00
TORC.V cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 0.00
TORC.V balance_sheet (annual, 2025-06-30) — Stockholders Equity: 2959790.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2959790.00
TORC.V balance_sheet (annual, 2025-06-30) — Tangible Book Value: 2959790.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 2959790.00
TORC.V income_statement (annual, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
TORC.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
TORC.V income_statement (annual, 2025-06-30) — Tax Provision: 0.00
TORC.V income_statement (annual, 2025-06-30) — Tax Rate For Calcs: 0.00
TORC.V income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
TORC.V balance_sheet (annual, 2025-06-30) — Total Assets: 4424641.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 4424641.00
TORC.V balance_sheet (annual, 2025-06-30) — Total Capitalization: 2959790.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 2959790.00
TORC.V balance_sheet (annual, 2025-06-30) — Total Debt: 680683.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Total Debt: 680683.00
TORC.V balance_sheet (annual, 2025-06-30) — Total Equity Gross Minority Interest: 2959790.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 2959790.00
TORC.V income_statement (annual, 2025-06-30) — Total Expenses: 539107.00
TORC.V income_statement (quarterly, 2025-06-30) — Total Expenses: 105107.00
TORC.V balance_sheet (annual, 2025-06-30) — Total Liabilities Net Minority Interest: 1464851.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1464851.00
TORC.V balance_sheet (annual, 2025-06-30) — Total Non Current Assets: 4366059.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 4366059.00
TORC.V balance_sheet (annual, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
TORC.V income_statement (annual, 2025-06-30) — Total Other Finance Cost: 1868.00
TORC.V income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 363.00
TORC.V income_statement (annual, 2025-06-30) — Total Unusual Items: -155529.00
TORC.V income_statement (quarterly, 2025-06-30) — Total Unusual Items: -164143.00
TORC.V income_statement (annual, 2025-06-30) — Total Unusual Items Excluding Goodwill: -155529.00
TORC.V income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -164143.00
TORC.V balance_sheet (annual, 2025-06-30) — Working Capital: -1406269.00
TORC.V balance_sheet (quarterly, 2025-06-30) — Working Capital: -1406269.00
TORC.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 124436.00
TORC.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 12249.00
TORC.V income_statement (quarterly, 2025-09-30) — Basic Average Shares: 11165689.00
TORC.V income_statement (quarterly, 2025-09-30) — Basic EPS: -0.01
TORC.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 30049.00
TORC.V cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -19739.00
TORC.V cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -19739.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 11424816.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 151101.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 151101.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Cash Financial: 151101.00
TORC.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 286061.00
TORC.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -19739.00
TORC.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -142191.00
TORC.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -36139.00
TORC.V cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 5138.00
TORC.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: -6068.00
TORC.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -37069.00
TORC.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: 124131.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 11424816.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 3185437.00
TORC.V cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 300000.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 719063.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 180603.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Current Debt: 716842.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 716842.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1467255.00
TORC.V cash_flow (quarterly, 2025-09-30) — Depreciation: 39.00
TORC.V cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 39.00
TORC.V income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 39.00
TORC.V cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 39.00
TORC.V income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 39.00
TORC.V income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 39.00
TORC.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 11165689.00
TORC.V income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.01
TORC.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -143067.00
TORC.V income_statement (quarterly, 2025-09-30) — EBIT: -123006.00
TORC.V income_statement (quarterly, 2025-09-30) — EBITDA: -122967.00
TORC.V cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -3079.00
TORC.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 151101.00
TORC.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 286061.00
TORC.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -161930.00
TORC.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 1907.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 1625697.00
TORC.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 46099.00
TORC.V cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
TORC.V income_statement (quarterly, 2025-09-30) — Insurance And Claims: 5594.00
TORC.V income_statement (quarterly, 2025-09-30) — Interest Expense: 20061.00
TORC.V income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 20061.00
TORC.V cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 2092.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 3902279.00
TORC.V cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -19739.00
TORC.V cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 300000.00
TORC.V cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 300000.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Net Debt: 565741.00
TORC.V cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 590.00
TORC.V income_statement (quarterly, 2025-09-30) — Net Income: -143067.00
TORC.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -143067.00
TORC.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -143067.00
TORC.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -143067.00
TORC.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -143067.00
TORC.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -143067.00
TORC.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -143067.00
TORC.V income_statement (quarterly, 2025-09-30) — Net Interest Income: -20538.00
TORC.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -20538.00
TORC.V cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -13939.00
TORC.V cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -19739.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 4472089.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 3185437.00
TORC.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -124874.00
TORC.V income_statement (quarterly, 2025-09-30) — Normalized Income: -144974.00
TORC.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -142191.00
TORC.V cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 590.00
TORC.V income_statement (quarterly, 2025-09-30) — Operating Income: -124436.00
TORC.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 15274385.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 716842.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 1625697.00
TORC.V income_statement (quarterly, 2025-09-30) — Other Gand A: 33005.00
TORC.V income_statement (quarterly, 2025-09-30) — Other Income Expense: 1907.00
TORC.V cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 37316.00
TORC.V income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 78298.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Other Payable: 31350.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Payables: 31350.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 750413.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 17253.00
TORC.V income_statement (quarterly, 2025-09-30) — Pretax Income: -143067.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Receivables: 12249.00
TORC.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 39.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -9865076.00
TORC.V income_statement (quarterly, 2025-09-30) — Salaries And Wages: 7500.00
TORC.V income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 0.00
TORC.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 46099.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 15274385.00
TORC.V cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 0.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 3185437.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 3185437.00
TORC.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
TORC.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 4652692.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 3185437.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 716842.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 3185437.00
TORC.V income_statement (quarterly, 2025-09-30) — Total Expenses: 124436.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1467255.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 4472089.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
TORC.V income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 477.00
TORC.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: 1907.00
TORC.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 1907.00
TORC.V balance_sheet (quarterly, 2025-09-30) — Working Capital: -1286652.00
TORC.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 107557.00
TORC.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 17157.00
TORC.V income_statement (quarterly, 2025-12-31) — Basic Average Shares: 15274385.00
TORC.V income_statement (quarterly, 2025-12-31) — Basic EPS: -0.01
TORC.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 151101.00
TORC.V cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -7363.00
TORC.V cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -7363.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 11424816.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 83451.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 83451.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Cash Financial: 83451.00
TORC.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 0.00
TORC.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -7363.00
TORC.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -69463.00
TORC.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 23957.00
TORC.V cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -244.00
TORC.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: -4909.00
TORC.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 18804.00
TORC.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: -76826.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 11424816.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 3058491.00
TORC.V cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 743038.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 118192.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Current Debt: 753909.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 753909.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1509547.00
TORC.V cash_flow (quarterly, 2025-12-31) — Depreciation: 0.00
TORC.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 0.00
TORC.V income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 0.00
TORC.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 0.00
TORC.V income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 0.00
TORC.V income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 0.00
TORC.V income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 15274385.00
TORC.V income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.01
TORC.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -125334.00
TORC.V income_statement (quarterly, 2025-12-31) — EBIT: -106430.00
TORC.V income_statement (quarterly, 2025-12-31) — EBITDA: -106430.00
TORC.V cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 9176.00
TORC.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 83451.00
TORC.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 0.00
TORC.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -76826.00
TORC.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -10.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1624085.00
TORC.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 32894.00
TORC.V cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
TORC.V income_statement (quarterly, 2025-12-31) — Insurance And Claims: 6094.00
TORC.V income_statement (quarterly, 2025-12-31) — Interest Expense: 18904.00
TORC.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 18904.00
TORC.V cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 0.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 3812400.00
TORC.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -7363.00
TORC.V cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
TORC.V cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Net Debt: 670458.00
TORC.V cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
TORC.V income_statement (quarterly, 2025-12-31) — Net Income: -125334.00
TORC.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -125334.00
TORC.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -125334.00
TORC.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -125334.00
TORC.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -125334.00
TORC.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -125334.00
TORC.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -125334.00
TORC.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -19305.00
TORC.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -19305.00
TORC.V cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 4449846.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 3058491.00
TORC.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -106420.00
TORC.V income_statement (quarterly, 2025-12-31) — Normalized Income: -125324.00
TORC.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -69463.00
TORC.V cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 0.00
TORC.V income_statement (quarterly, 2025-12-31) — Operating Income: -107557.00
TORC.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 15274385.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 753909.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 1624085.00
TORC.V income_statement (quarterly, 2025-12-31) — Other Gand A: 19300.00
TORC.V income_statement (quarterly, 2025-12-31) — Other Income Expense: 1528.00
TORC.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 37067.00
TORC.V income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 1538.00
TORC.V income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 74663.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Other Payable: 12600.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Payables: 12600.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 755638.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 17584.00
TORC.V income_statement (quarterly, 2025-12-31) — Pretax Income: -125334.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Receivables: 17157.00
TORC.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 0.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -9990410.00
TORC.V income_statement (quarterly, 2025-12-31) — Salaries And Wages: 7500.00
TORC.V income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 0.00
TORC.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 32894.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 15274385.00
TORC.V cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 0.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 3058491.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 3058491.00
TORC.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
TORC.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 4568038.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 3058491.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 753909.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 3058491.00
TORC.V income_statement (quarterly, 2025-12-31) — Total Expenses: 107557.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1509547.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 4449846.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
TORC.V income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 401.00
TORC.V income_statement (quarterly, 2025-12-31) — Total Unusual Items: -10.00
TORC.V income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -10.00
TORC.V balance_sheet (quarterly, 2025-12-31) — Working Capital: -1391355.00
TORC.V income_statement (quarterly, 2026-03-31) — +Operating Expense: 147455.00
TORC.V income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 21916.00
TORC.V income_statement (quarterly, 2026-03-31) — Basic Average Shares: 17137375.00
TORC.V income_statement (quarterly, 2026-03-31) — Basic EPS: -0.01
TORC.V cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 83451.00
TORC.V cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -7215.00
TORC.V cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -7215.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Capital Stock: 12317064.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 40432.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 40432.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Cash Financial: 40432.00
TORC.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 26053.00
TORC.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -7215.00
TORC.V cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -61301.00
TORC.V cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 87870.00
TORC.V cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -11580.00
TORC.V cash_flow (quarterly, 2026-03-31) — Change In Receivables: -4736.00
TORC.V cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 71554.00
TORC.V cash_flow (quarterly, 2026-03-31) — Changes In Cash: -42463.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Common Stock: 12317064.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 3891972.00
TORC.V cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 831943.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Current Assets: 91750.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 846389.00
TORC.V cash_flow (quarterly, 2026-03-31) — Depreciation: 0.00
TORC.V cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 0.00
TORC.V income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 0.00
TORC.V cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 0.00
TORC.V income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 0.00
TORC.V income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 0.00
TORC.V income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 17137375.00
TORC.V income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.01
TORC.V income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -166497.00
TORC.V income_statement (quarterly, 2026-03-31) — EBIT: -146723.00
TORC.V income_statement (quarterly, 2026-03-31) — EBITDA: -146723.00
TORC.V cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -556.00
TORC.V cash_flow (quarterly, 2026-03-31) — End Cash Position: 40432.00
TORC.V cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 26053.00
TORC.V cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -68516.00
TORC.V income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 1233.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 1731815.00
TORC.V income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 58139.00
TORC.V income_statement (quarterly, 2026-03-31) — Insurance And Claims: 7425.00
TORC.V income_statement (quarterly, 2026-03-31) — Interest Expense: 19774.00
TORC.V income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 19774.00
TORC.V cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 0.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Invested Capital: 3891972.00
TORC.V cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -7215.00
TORC.V cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
TORC.V cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
TORC.V cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
TORC.V income_statement (quarterly, 2026-03-31) — Net Income: -166497.00
TORC.V income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -166497.00
TORC.V income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -166497.00
TORC.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -166497.00
TORC.V income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -166497.00
TORC.V cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -166497.00
TORC.V income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -166497.00
TORC.V income_statement (quarterly, 2026-03-31) — Net Interest Income: -20275.00
TORC.V cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 0.00
TORC.V income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -20275.00
TORC.V cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Net PPE: 4646611.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 3891972.00
TORC.V income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -147956.00
TORC.V income_statement (quarterly, 2026-03-31) — Normalized Income: -167730.00
TORC.V cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -61301.00
TORC.V cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 0.00
TORC.V income_statement (quarterly, 2026-03-31) — Operating Income: -147455.00
TORC.V income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 21890585.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 1731815.00
TORC.V income_statement (quarterly, 2026-03-31) — Other Gand A: 43214.00
TORC.V income_statement (quarterly, 2026-03-31) — Other Income Expense: 1233.00
TORC.V cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 33642.00
TORC.V income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 89316.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Other Payable: 14446.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Payables: 14446.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 846389.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 29402.00
TORC.V income_statement (quarterly, 2026-03-31) — Pretax Income: -166497.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Receivables: 21916.00
TORC.V income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 0.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -10156907.00
TORC.V income_statement (quarterly, 2026-03-31) — Salaries And Wages: 7500.00
TORC.V cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 0.00
TORC.V income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 0.00
TORC.V income_statement (quarterly, 2026-03-31) — Selling General And Administration: 58139.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Share Issued: 21890585.00
TORC.V cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 0.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 3891972.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 3891972.00
TORC.V income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
TORC.V income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Total Assets: 4738361.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 3891972.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 3891972.00
TORC.V income_statement (quarterly, 2026-03-31) — Total Expenses: 147455.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 846389.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 4646611.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
TORC.V income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 501.00
TORC.V income_statement (quarterly, 2026-03-31) — Total Unusual Items: 1233.00
TORC.V income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 1233.00
TORC.V balance_sheet (quarterly, 2026-03-31) — Working Capital: -754639.00
TORNTPHARM.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 1472000000.00
TORNTPHARM.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 4157000000.00
TORNTPHARM.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 338445440.00
TORNTPHARM.NS income_statement (annual, 2022-03-31) — Basic EPS: 22.96
TORNTPHARM.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 338445440.00
TORNTPHARM.NS income_statement (annual, 2022-03-31) — Diluted EPS: 22.96
TORNTPHARM.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 40000000.00
TORNTPHARM.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 29166800000.00
TORNTPHARM.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 24600000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — +Operating Expense: 44959800000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — +Total Revenue: 94636900000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 16788000000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 19438200000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -18203900000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 1071400000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -108500000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Amortization: 4765600000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 4765600000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 711100000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 338445440.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Basic EPS: 36.79
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 3984000000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 12322200000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -5739400000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 712600000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 1692300000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 5085300000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 7227500000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -8630400000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 379800000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 4705500000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 2557100000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 931100000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Change In Payable: -580200000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -3090000000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -182000000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 301800000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Common Stock: 1692300000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 61980700000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 7107100000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 28276900000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Current Assets: 53137200000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 183300000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Current Debt: 28010800000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 28194100000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 54473000000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 3937100000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Depreciation: 2254700000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 7020300000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 7020300000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 2254700000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Derivative Product Liabilities: 91100000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 338445440.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Diluted EPS: 36.79
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 12452300000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 48000000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — EBIT: 21794000000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — EBITDA: 28814300000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 211200000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — End Cash Position: 5085300000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Financial Assets: 0.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 773600000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 13034200000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 17941900000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -195100000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -216200000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 6137600000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Goodwill: 3375000000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 54270100000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 19546700000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 53027000000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Gross Profit: 66360000000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 0.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 45600000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Interest Expense: 3322400000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 3322400000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Interest Income: 147800000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 147800000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -3030200000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 129000000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Inventory: 22296400000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 114953700000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -24153100000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 711100000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 13950000000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 7598300000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 529300000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 24962200000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 25491500000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 13950000000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -9718400000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 3930600000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 23543900000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Minority Interests: 0.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -20000000000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Net Debt: 47887700000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -491500000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Net Income: 12452300000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 12452300000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 12452300000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 12452300000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 12452300000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 18471600000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 12452300000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Net Interest Income: -3186600000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -129800000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 12651900000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 4231600000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -3186600000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Net PPE: 34823100000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -4152300000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 8420300000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 7710600000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 14600000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 5436700000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 4019400000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 202700000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 28448600000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Normalized Income: 12205781630.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 23681300000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Operating Income: 21400200000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Operating Revenue: 94636900000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 338445440.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 588300000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 3030000000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 1030000000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 60290000000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 50895100000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 572600000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 3186600000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 220000000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 20000000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 73100000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 5133100000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Other Payable: 3940600000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Other Properties: 2455500000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 1819100000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 2142200000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Other Special Charges: -216200000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Payables: 21089700000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 1265600000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Pretax Income: 18471600000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 22700000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: -20000000000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -603800000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -5739400000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 7524900000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 28276900000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 7020300000.00
TORNTPHARM.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -9718400000.00
TORNTPHARM.NS income_statement (annual, 2023-03-31) — Research And Development: 312700000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 48000000.00
TORNTPHARM.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 33031900000.00